EP0076062B1 - Blood product storage bag - Google Patents

Blood product storage bag Download PDF

Info

Publication number
EP0076062B1
EP0076062B1 EP82304876A EP82304876A EP0076062B1 EP 0076062 B1 EP0076062 B1 EP 0076062B1 EP 82304876 A EP82304876 A EP 82304876A EP 82304876 A EP82304876 A EP 82304876A EP 0076062 B1 EP0076062 B1 EP 0076062B1
Authority
EP
European Patent Office
Prior art keywords
juncture
closure seam
bag according
bag
weakenings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP82304876A
Other languages
German (de)
French (fr)
Other versions
EP0076062B2 (en
EP0076062A3 (en
EP0076062A2 (en
Inventor
Richard M. Lueptow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Latham Labs Inc Te Braintree Massachusetts Ver
Original Assignee
Haemonetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23181023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0076062(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haemonetics Corp filed Critical Haemonetics Corp
Priority to AT82304876T priority Critical patent/ATE20821T1/en
Publication of EP0076062A2 publication Critical patent/EP0076062A2/en
Publication of EP0076062A3 publication Critical patent/EP0076062A3/en
Application granted granted Critical
Publication of EP0076062B1 publication Critical patent/EP0076062B1/en
Publication of EP0076062B2 publication Critical patent/EP0076062B2/en
Expired legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers

Definitions

  • This invention relates generally to the field of blood component therapy and more particularly relates to containers for apparatus for the collecting, storing and dispensing of blood plasma to be processed into blood components such as albumin, globulins and so on.
  • a relatively modern medical technology known as blood component therapy involves administering to a patient just that part of the blood that he actually needs. Rather than whole blood, the physician decides what portion or component of blood is necessary for the patient and administers only that component to him. He, thus, avoids many of the hazards which are inherent in whole blood usage. Not only is the practice better for the patient in that certain risks involving transfusing whole blood are reduced, but it permits one unit of donated blood to be used for more than one patient. For example, from one unit of whole blood, which subsequently is fractionated, there may be derived red blood cells, platelets, fresh plasma, frozen or stored plasma, albumin, globulins and so on.
  • cell separators permit the separation of blood into its components while the donor is in the process of making a donation.
  • a blood bank it is possible for a blood bank to take from the donor specific components which are needed by a patient while other components are returned simultaneously to the donor.
  • the plasma is separated from the cellular elements of the blood and the cells returned to the donor.
  • the plasma is then subsequently used for blood volume expansion or blood augmentation in the form of stored plasma or fresh frozen plasma.
  • the plasma can also be processed into a number of useful products such as albumin, globulins and antihemophiliac factor. It is to this purpose that the present invention is directed.
  • Blood is collected from the donor in a connected, sealed collection system and then centrifuged to separate the cells and the plasma.
  • the cells are returned to the donor and the plasma is subsequently frozen in a collection bag.
  • the plasma may be stored for a number of months before being removed for plasma component manufacturing. Subsequently, large quantities of plasma are batch processed, i.e. plasma from many donors.
  • the system just described is the subject of GB-A-2,044,220.
  • the blood product collection bag of that system is made of flexible material and has a body with front and rearfaces and there is a closure seam at or adjacent an end of the body. As noted above, this bag has to be cut open to free the frozen plasma, which is then ejected from the bag by squeezing the bag.
  • the present practice involves receiving blood from the donor in a collection system and centrifuging it so that the plasma is collected in one of the bags of the system.
  • the plasma containing bag is then separated from the rest of the collection system and is stored after freezing its contents, all prior to processing weeks or months later. Subsequently, many bags are opened, and the plasma put in a container for batch processing.
  • the present invention is directed to an "easy-open" plasma bag which need not be cut to remove the plasma.
  • the "easy-open" bag which holds the plasma is a sealable container of flexible material. It comprises a body so constructed that a manually applied opening force exerted thereon causes the body to rupture at predetermined locations and to tear open along predetermined lines, thus affording separation of the body from the frozen plasma without any necessity for the bag being cut by a knife or any other instrument, or for the plasma to be contacted by the hands.
  • a blood product storage bag made of .flexible material and having a body with front and rear faces and a closure seam at or adjacent an end of the body, characterised by the body having an easy-open frangible construction provided by opposed weakenings, one in each of the said faces, which extend to the closure seam and are aligned with one another thereat, and stress-concentrating means which concentrate an applied opening force at the juncture of the seam and said weakenings for causing the body to rupture at the juncture and be torn open along the weakenings to separate the bag from its contents.
  • the closure seam can be of V-shape configuration, the point of which intersects the juncture, the said closure seam defining a V-shape removable portion of body material on the side of the closure seam which is opposite the weakenings whereby the closure seam may be ruptured at the juncture and the body torn open along the weakenings to separate it from its contents after the V-shape body material is removed.
  • the bag is provided with means which may be gripped by hand to facilitate the application of the rupturing force.
  • the bag is preferably formed of a material which is capable of remaining flexible at temperatures of -25 to -80°C, e.g. of polyolefinic type.
  • Fig. 1 shows a transfer bag embodying the present invention.
  • the bag was used as part of multiple bag collection system and is now in an inverted position and containing frozen plasma ready for opening.
  • the body 10 of the bag communicated with a donor bag (not shown) by means of a flexible tube 12, the tube now being closed by a conventional seal 14.
  • the bag includes hanger holes 16 which may be employed when the donor bag is being filled.
  • the bag comprises a sealable container of flexible plastics material such as polyolefin of 6 mils thickness (0.15 mm) which is capable of remaining flexible at temperatures of -25 to -80°C, i.e. the range of temperatures in which plasma is frozen and stored.
  • the body 10 of the container includes a pair of weakening lines comprising frangible seams 20 or similar running from the.top to the bottom of the body (as oriented in Fig. 1).
  • the seams join one another at a juncture 22.
  • the lines 20 will be seen to be located at opposite sides of the body 10 and in a plane bisecting the body.
  • a closure seam 24 Transversely intersecting the juncture 22 of the frangible lines 20 is a closure seam 24 which is of greater width than the width of the frangible seams.
  • a pair of ears 26 lie laterally of the juncture 22 to one side of (in this instance above) the closure seam 24, opposite the frangible lines 20.
  • the edges of the ears 26 are rounded and converge toward the juncture 22.
  • the closure seam 24 is essentially along a straight line, sealing the top of the bag and separating the interior of the body from the ears 26.
  • ribs 28 are formed in the body and extend from the closure seam 24 in diverging directions away from the juncture 22 to the edges of the body 10.
  • the ribs 28 define portions 30 of the body lying laterally of the juncture which are sealed from the interior of the body and accordingly contain no plasma.
  • the ears 26 alone or together with the closure seam 24 and/or the portions 30 are gripped and pulled apart either as shown in Fig. 2 or in Fig. 3, thereby directing or concentrating force at the juncture 22.
  • the bag ruptures at the juncture 22 permitting the body 10 to be torn apart along the frangible lines 20 whereby the flexible plastics film may be peeled away from the frozen plasma within the bag and the plasma allowed to fall into a collection container without being touched by a knife or other opening instrument, or by the hands.
  • the bag of course would be inverted from the positions shown in Figs. 1, 2 and 3 for releasing its contents. While Figs. 2 and 3 show the flexible container being torn apart by bare hands, some may prefer to wear gloves as insulation from the cold contents.
  • opening required the bag to be cut open with a knife to expose the plasma as well as thawing of its contents slightly from the outside inwardly to release the frozen plasma from the inner surface of the bag. Because of the construction of the present invention, the bag need not be cut. Since the bag is essentially peeled back away from the frozen plasma, there is no skin thawing necessary preparatory to opening the bag.
  • Fig. 4. shows an alternative construction of the openable portion of the bag.
  • the closure seam 24, as in the Fig. 1 construction, is essentially a straight line running across top of the bag intersecting the juncture with the frangible lines 20.
  • the closure seam 24 has a notch 34 aligned with the juncture 22 to concentrate rupturing force at the juncture 22.
  • FIG. 5 Another alternative construction of the body is shown in Fig. 5.
  • the closure seam 24 is of V-shape configuration comprising portions 24a and 24b converging toward the juncture 22.
  • Ribs 28 define areas 30 equivalent to the portions 30 in the Fig. 1 construction. Again, the ribs 28 and unfilled areas 30 are optional. However, since there are no ears, it would be the closure seam portions 24a and 24b (with the portions 30 if provided) that would be gripped and pulled apart.
  • the V-shape configuration of the seam 24 concentrates the applied force at the juncture 22 to initiate tearing of the frangible lines 20.
  • Figs. 6 and 7 show another alternative construction.
  • the closure seam 24 as in the Fig. 5 construction is of V-shape configuration converging at the juncture with the frangible seams 20.
  • the ribs 28a and 28b also converge at the juncture and as described above define unfilled areas 30.
  • the ribs 28a and 28b converge at the juncture.
  • the closure seam portions 24a and the rib 28a are aligned linear extensions of each other as are the seam portion 24b and the rib 28b.
  • the triangular portion 40 remains attached to the bag until it is ready to be opened. It will be noted in Fig. 6 that a line of serrations 46 extend along the closure seam portions 24a and 24b. The provision of the triangular portion 40 lends additional strength to the bag to guarantee against premature rupture at the juncture 22.
  • the portion 40 is torn from the bag along the lines of serration 46 rendering the bag as it appears in Fig. 7. Thereafter, the portions 30 and/or the closure seam portions 24a and 24b may be gripped and pulled apart to develop and concentrate rupturing force at the juncture 22 as in above described constructions.
  • the various constructions may be fabricated in various ways. They may be made by cutting off blanks from a continuous tube of polyolefin material and forming the frangible lines 20, the bottom 36, the closure seam 24, and the ribs 28 by heat sealing. Another method of fabrication would be to start with sheet material folded upon itself with the various ribs, seams and lines also formed by heat sealing.
  • Another method would be by forming the entire bag by blow molding.
  • the various ribs, seams and lines would be formed in the mold cavity and imparted to the bag in the blow molding process.

Abstract

An easy-open container for the storage of blood components is a bag of flexible material having a body (10) provided with frangible seams (20) which join at an apex (22) of the body; a closure seam (24) transversely intersects the apex (22) and is designed to be ruptured at the apex (22) so that the body (10) can be torn open along the frangible seams (20) to separate it from its contents, when the bag is gripped to either side of the apex (22) and pulled apart.

Description

  • This invention relates generally to the field of blood component therapy and more particularly relates to containers for apparatus for the collecting, storing and dispensing of blood plasma to be processed into blood components such as albumin, globulins and so on.
  • A relatively modern medical technology known as blood component therapy involves administering to a patient just that part of the blood that he actually needs. Rather than whole blood, the physician decides what portion or component of blood is necessary for the patient and administers only that component to him. He, thus, avoids many of the hazards which are inherent in whole blood usage. Not only is the practice better for the patient in that certain risks involving transfusing whole blood are reduced, but it permits one unit of donated blood to be used for more than one patient. For example, from one unit of whole blood, which subsequently is fractionated, there may be derived red blood cells, platelets, fresh plasma, frozen or stored plasma, albumin, globulins and so on.
  • Furthermore, in the most modern techniques, cell separators permit the separation of blood into its components while the donor is in the process of making a donation. Through modern technology it is possible for a blood bank to take from the donor specific components which are needed by a patient while other components are returned simultaneously to the donor.
  • In the technique known as plasmapheresis, the plasma is separated from the cellular elements of the blood and the cells returned to the donor. The plasma is then subsequently used for blood volume expansion or blood augmentation in the form of stored plasma or fresh frozen plasma. The plasma can also be processed into a number of useful products such as albumin, globulins and antihemophiliac factor. It is to this purpose that the present invention is directed.
  • Blood is collected from the donor in a connected, sealed collection system and then centrifuged to separate the cells and the plasma. The cells are returned to the donor and the plasma is subsequently frozen in a collection bag. In the frozen state the plasma may be stored for a number of months before being removed for plasma component manufacturing. Subsequently, large quantities of plasma are batch processed, i.e. plasma from many donors.
  • During this batch processing contamination is an obvious risk. The whole blood is initially collected in a sealed system which is followed by centrifuging and freezing while still sealed. However, the bags must ultimately be cut open and the plasma removed either manually or automatically. It is possible that during the opening and removing operation the plasma can become contaminated.
  • The system just described is the subject of GB-A-2,044,220. The blood product collection bag of that system is made of flexible material and has a body with front and rearfaces and there is a closure seam at or adjacent an end of the body. As noted above, this bag has to be cut open to free the frozen plasma, which is then ejected from the bag by squeezing the bag.
  • The present practice involves receiving blood from the donor in a collection system and centrifuging it so that the plasma is collected in one of the bags of the system. The plasma containing bag is then separated from the rest of the collection system and is stored after freezing its contents, all prior to processing weeks or months later. Subsequently, many bags are opened, and the plasma put in a container for batch processing. The present invention is directed to an "easy-open" plasma bag which need not be cut to remove the plasma.
  • Whilst easy-open packaging such as bags and other containers are known for containing various products, see for example US-A-3,259,235, US-A-3,516,537 and US-A-3,604,616, so far as we know no-one hitherto has devised an easy-open arrangement suiting the requirements of a blood product storage bag.
  • The "easy-open" bag which holds the plasma is a sealable container of flexible material. It comprises a body so constructed that a manually applied opening force exerted thereon causes the body to rupture at predetermined locations and to tear open along predetermined lines, thus affording separation of the body from the frozen plasma without any necessity for the bag being cut by a knife or any other instrument, or for the plasma to be contacted by the hands.
  • According to the present invention, there is provided a blood product storage bag made of .flexible material and having a body with front and rear faces and a closure seam at or adjacent an end of the body, characterised by the body having an easy-open frangible construction provided by opposed weakenings, one in each of the said faces, which extend to the closure seam and are aligned with one another thereat, and stress-concentrating means which concentrate an applied opening force at the juncture of the seam and said weakenings for causing the body to rupture at the juncture and be torn open along the weakenings to separate the bag from its contents.
  • The closure seam can be of V-shape configuration, the point of which intersects the juncture, the said closure seam defining a V-shape removable portion of body material on the side of the closure seam which is opposite the weakenings whereby the closure seam may be ruptured at the juncture and the body torn open along the weakenings to separate it from its contents after the V-shape body material is removed.
  • Preferably, the bag is provided with means which may be gripped by hand to facilitate the application of the rupturing force. Moreover, the bag is preferably formed of a material which is capable of remaining flexible at temperatures of -25 to -80°C, e.g. of polyolefinic type.
  • The present invention will now be more particularly described with reference to the accompanying drawings in which containers embodying the invention are shown by way of exemplary illustration only. The principles of this invention may be employed in other embodiments without departing from the scope of the appended claims. In the drawings:
    • Fig. 1 is a perspective view of an "easy-open" sealable container or bag of flexible material embodying the invention;
    • Figs. 2 and 3 are views of the bag shown in Fig. 1 being opened;
    • Figs. 4 and 5 are views of alternative bag constructions according to the invention; and
    • Figs. 6 and 7 are views of another alternative bag construction according to the invention.
  • Fig. 1 shows a transfer bag embodying the present invention. The bag was used as part of multiple bag collection system and is now in an inverted position and containing frozen plasma ready for opening. The body 10 of the bag communicated with a donor bag (not shown) by means of a flexible tube 12, the tube now being closed by a conventional seal 14. The bag includes hanger holes 16 which may be employed when the donor bag is being filled. The bag comprises a sealable container of flexible plastics material such as polyolefin of 6 mils thickness (0.15 mm) which is capable of remaining flexible at temperatures of -25 to -80°C, i.e. the range of temperatures in which plasma is frozen and stored.
  • Depending on its method of manufacture, the body 10 of the container includes a pair of weakening lines comprising frangible seams 20 or similar running from the.top to the bottom of the body (as oriented in Fig. 1). The seams join one another at a juncture 22.
  • As viewed in Figs. 2 and 3 (which is a view only slightly in perspective of the openable end of the bag), the lines 20 will be seen to be located at opposite sides of the body 10 and in a plane bisecting the body. Transversely intersecting the juncture 22 of the frangible lines 20 is a closure seam 24 which is of greater width than the width of the frangible seams. In the construction shown in Figs. 1, 2 and 3 a pair of ears 26 lie laterally of the juncture 22 to one side of (in this instance above) the closure seam 24, opposite the frangible lines 20. The edges of the ears 26 are rounded and converge toward the juncture 22. The closure seam 24 is essentially along a straight line, sealing the top of the bag and separating the interior of the body from the ears 26.
  • Also as seen in Figs. 1 and 2 (but hidden in Fig. 3) ribs 28 are formed in the body and extend from the closure seam 24 in diverging directions away from the juncture 22 to the edges of the body 10. The ribs 28 define portions 30 of the body lying laterally of the juncture which are sealed from the interior of the body and accordingly contain no plasma.
  • To open the body, the ears 26 alone or together with the closure seam 24 and/or the portions 30 are gripped and pulled apart either as shown in Fig. 2 or in Fig. 3, thereby directing or concentrating force at the juncture 22. The bag ruptures at the juncture 22 permitting the body 10 to be torn apart along the frangible lines 20 whereby the flexible plastics film may be peeled away from the frozen plasma within the bag and the plasma allowed to fall into a collection container without being touched by a knife or other opening instrument, or by the hands. The bag of course would be inverted from the positions shown in Figs. 1, 2 and 3 for releasing its contents. While Figs. 2 and 3 show the flexible container being torn apart by bare hands, some may prefer to wear gloves as insulation from the cold contents.
  • In some prior plasma bag constructions, opening required the bag to be cut open with a knife to expose the plasma as well as thawing of its contents slightly from the outside inwardly to release the frozen plasma from the inner surface of the bag. Because of the construction of the present invention, the bag need not be cut. Since the bag is essentially peeled back away from the frozen plasma, there is no skin thawing necessary preparatory to opening the bag.
  • Fig. 4.shows an alternative construction of the openable portion of the bag. The closure seam 24, as in the Fig. 1 construction, is essentially a straight line running across top of the bag intersecting the juncture with the frangible lines 20. The closure seam 24 has a notch 34 aligned with the juncture 22 to concentrate rupturing force at the juncture 22. There are no ears 26 on the body and it would be optional to provide ribs 28 defining the sealed portions 30 containing no plasma.
  • Another alternative construction of the body is shown in Fig. 5. In this alternative the closure seam 24 is of V-shape configuration comprising portions 24a and 24b converging toward the juncture 22. Ribs 28 define areas 30 equivalent to the portions 30 in the Fig. 1 construction. Again, the ribs 28 and unfilled areas 30 are optional. However, since there are no ears, it would be the closure seam portions 24a and 24b (with the portions 30 if provided) that would be gripped and pulled apart. The V-shape configuration of the seam 24 concentrates the applied force at the juncture 22 to initiate tearing of the frangible lines 20.
  • Figs. 6 and 7 show another alternative construction. The closure seam 24 as in the Fig. 5 construction is of V-shape configuration converging at the juncture with the frangible seams 20. The ribs 28a and 28b also converge at the juncture and as described above define unfilled areas 30.
  • For ease of construction, the ribs 28a and 28b converge at the juncture. The closure seam portions 24a and the rib 28a are aligned linear extensions of each other as are the seam portion 24b and the rib 28b. By this configuration, there is a substantially triangular portion 40 on the side of the closure seam 24a-24b opposite the areas 30 which is made up of the folded overlapping corners of the bag material designated 42. These are secured together by a combining seam 44.
  • The triangular portion 40 remains attached to the bag until it is ready to be opened. It will be noted in Fig. 6 that a line of serrations 46 extend along the closure seam portions 24a and 24b. The provision of the triangular portion 40 lends additional strength to the bag to guarantee against premature rupture at the juncture 22.
  • When the bag is ready to be opened, the portion 40 is torn from the bag along the lines of serration 46 rendering the bag as it appears in Fig. 7. Thereafter, the portions 30 and/or the closure seam portions 24a and 24b may be gripped and pulled apart to develop and concentrate rupturing force at the juncture 22 as in above described constructions.
  • The various constructions may be fabricated in various ways. They may be made by cutting off blanks from a continuous tube of polyolefin material and forming the frangible lines 20, the bottom 36, the closure seam 24, and the ribs 28 by heat sealing. Another method of fabrication would be to start with sheet material folded upon itself with the various ribs, seams and lines also formed by heat sealing.
  • Another method would be by forming the entire bag by blow molding. The various ribs, seams and lines would be formed in the mold cavity and imparted to the bag in the blow molding process.

Claims (14)

1. A blood product storage bag made of flexible material and having a body (10) with front and rear faces and a closure seam (24) at or adjacent an end of the body, characterised by the body (10) having an easy-open frangible construction provided by opposed weakenings (20), one in each of the said faces, which extend to the closure seam (24) and are aligned with one another thereat, and stress-concentrating means (e.g. 34) which concentrate an applied opening force at the juncture (22) of the seam (24) and said weakenings (20) for causing the body to rupture at the juncture (22) and be torn open along the weakenings (20) to separate the bag from its contents.
2. A bag according to claim 1, characterised by portions (26 or 30) of the body (10) being located laterally of the juncture (22) and providing means to be gripped for applying the opening force which is concentrated at the juncture (22).
3. A bag according to claim 1 or claim 2, characterised by ribs (28) extending from the closure seam (24) and diverging away from the juncture (22) to define unfilled areas (30) of the body (10) which may be gripped to apply the opening force which is concentrated at the juncture (22).
4. A bag according to claim 3, characterised in that the ribs (28a, 28b) are aligned linear extensions of a V-shape closure seam (24).
5. A bag according to claim 1, 2, 3 or 4, characterised in that portions (26) of the flexible material lie laterally of the juncture (22) on the side of the closure seam (24) opposite the weakenings (20) and are formed to concentrate the opening force at the juncture when the lateral portions (26) are pulled apart.
6. A bag according to any of claims 1 to 3 or 5 characterised in that the closure seam (24) is essentially along a straight line.
7. A bag according to any of claims 1 to 5, characterised in that the closure seam (24) is of V-shape converging at the juncture (22) to concentrate the said force thereat.
8. A bag according to any of claims 1 to 7, characterised in that the closure seam (24) is notched (at 34) to concentrate the opening force at the juncture (22).
9. A bag according to any of claims 1 to 8, characterised in that the body (10) is formed from sheet and seams forming the weakenings (20) and closure seam (24) are formed by heat sealing.
10. A bag according to any of claims 1 to 8, characterised in that the body (10) is formed by blow molding.
11. A bag according to any of claims 1 to 10, made from plastics material which is capable of remaining flexible at temperatures of -25°C to -80°C.
12. A bag according to any of claims 1 to 11, characterised by having removable material (40, 42) to one side of the closure seam (24) opposite the weakenings (20) to strengthen the container and render the closure seam (24) unlikely to be ruptured prematurely.
13. A bag according to any of claims 1 to 1,1, characterised by the closure seam (24) being of V-shape configuration the point of which V intersects the juncture (22), the said closure seam defining a V-shape removable portion (40) of body material on the side of the closure seam which is opposite the weakenings (20) whereby the closure seam (24) may be ruptured at the juncture (22) and the body (10) torn open along the weakenings (20) to separate it from its contents after the V-shape body material is removed.
14. A bag according to claim 13, characterised by lines of weakness (46) separating the removable portion (40) from the remainder of the body (10).
EP82304876A 1981-09-25 1982-09-16 Blood product storage bag Expired EP0076062B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT82304876T ATE20821T1 (en) 1981-09-25 1982-09-16 CONTAINERS FOR STORING BLOOD COMPONENTS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30549081A 1981-09-25 1981-09-25
US305490 2002-11-26

Publications (4)

Publication Number Publication Date
EP0076062A2 EP0076062A2 (en) 1983-04-06
EP0076062A3 EP0076062A3 (en) 1984-03-28
EP0076062B1 true EP0076062B1 (en) 1986-07-23
EP0076062B2 EP0076062B2 (en) 1989-12-27

Family

ID=23181023

Family Applications (1)

Application Number Title Priority Date Filing Date
EP82304876A Expired EP0076062B2 (en) 1981-09-25 1982-09-16 Blood product storage bag

Country Status (7)

Country Link
EP (1) EP0076062B2 (en)
JP (1) JPS5864953A (en)
AT (1) ATE20821T1 (en)
AU (1) AU8756582A (en)
DE (1) DE3272155D1 (en)
DK (1) DK426382A (en)
ES (1) ES276158Y (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133383A (en) * 1983-01-14 1984-07-25 Scottish Health Service Common Plasma bags
EP0159792A3 (en) * 1984-03-16 1986-11-20 Tuta Laboratories (Australia) Pty Ltd. Bag stripping machine
GB2161453B (en) * 1984-07-13 1989-05-17 Tuta Lab Plasma bags

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE533018A (en) *
US3051368A (en) * 1958-11-28 1962-08-28 Schneider Dispensing container
US3412918A (en) * 1966-10-31 1968-11-26 Phillips Petroleum Co Dispensing container
JPS4813052U (en) * 1971-06-25 1973-02-14
US3913789A (en) * 1974-02-13 1975-10-21 United States Banknote Corp Fluid container of the flexible wall capsule type
US4253458A (en) * 1979-03-08 1981-03-03 Baxter Travenol Laboratories, Inc. Method and apparatus for collecting blood plasma
JPS55158844U (en) * 1979-05-02 1980-11-14
JPS5943225Y2 (en) * 1980-11-10 1984-12-20 株式会社生産日本社 Synthetic resin bag
FR2495583A1 (en) * 1980-12-09 1982-06-11 Boncolac Sa Individual packing for ice cream - is of conical form and is opened by tearing from base point along tear lines

Also Published As

Publication number Publication date
DK426382A (en) 1983-03-26
JPS5864953A (en) 1983-04-18
EP0076062B2 (en) 1989-12-27
DE3272155D1 (en) 1986-08-28
AU8756582A (en) 1983-03-31
ATE20821T1 (en) 1986-08-15
ES276158Y (en) 1985-03-01
JPH0563381B2 (en) 1993-09-10
EP0076062A3 (en) 1984-03-28
ES276158U (en) 1984-08-01
EP0076062A2 (en) 1983-04-06

Similar Documents

Publication Publication Date Title
US4480751A (en) Apparatus for collecting, storing and dispensing frozen blood plasma
US5306269A (en) Bottom blood bag separation system
US4116338A (en) Package for sterile article
US5033868A (en) Flexible plastic bag with perforated handle
US5770051A (en) Apparatus for separating blood in an integrally formed container
US4198972A (en) Blood and blood component storage bags
US4253458A (en) Method and apparatus for collecting blood plasma
US3862684A (en) Aseptic packing container and method of making and filling it
CA1311449C (en) Flexible thermoplastic pouches having easy-open tear strip means and apparatus for making same
US5253754A (en) Peel package and method of packaging organs
US5897052A (en) Easily laterally opened type paper container
US3674195A (en) Filled and sealed easily opened bag and method of making same
US5971971A (en) Pouch for packaging biologic liquid substances with peelable opening for insertion of cannulae, tubes and probes
JPH06511452A (en) Bag-like packaging of cylindrical film, especially for sanitary towels and similar items
US4715528A (en) Reclosable opening arrangement on a packing container
US4190154A (en) Sterile package
CA1128004A (en) Peelable seal
EP0076062B1 (en) Blood product storage bag
US3254829A (en) Sealing of thermoplastic containers
JP5101054B2 (en) Easy-open packaging
JPS6240926Y2 (en)
JPH0427808Y2 (en)
GB2131384A (en) Packaging for surgical apparatus
JPH0262257B2 (en)
JPH08187282A (en) Blood bag

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT CH DE FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): AT CH DE FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19840502

ITF It: translation for a ep patent filed

Owner name: BARZANO' E ZANARDO MILANO S.P.A.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT CH DE FR GB IT LI NL SE

REF Corresponds to:

Ref document number: 20821

Country of ref document: AT

Date of ref document: 19860815

Kind code of ref document: T

ET Fr: translation filed
REF Corresponds to:

Ref document number: 3272155

Country of ref document: DE

Date of ref document: 19860828

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19860930

Year of fee payment: 5

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

26 Opposition filed

Opponent name: BIOTEST PHARMA GMBH

Effective date: 19870410

NLR1 Nl: opposition has been filed with the epo

Opponent name: BIOTEST PHARMA GMBH

26 Opposition filed

Opponent name: FISONS PLC

Effective date: 19870417

NLR1 Nl: opposition has been filed with the epo

Opponent name: FISONS PLC

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19870930

Year of fee payment: 6

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: LATHAM LABS. INC.

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: HAEMONETICS CORPORATION(A MASSACHUSETTS CORPORATIO

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: LATHAM LABS. INC. TE BRAINTREE, MASSACHUSETTS, VER

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Effective date: 19880916

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19880917

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19880930

Ref country code: CH

Effective date: 19880930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19890401

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

ITF It: translation for a ep patent filed

Owner name: BARZANO' E ZANARDO MILANO S.P.A.

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 19891227

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): AT CH DE FR GB IT LI NL SE

ET3 Fr: translation filed ** decision concerning opposition
EUG Se: european patent has lapsed

Ref document number: 82304876.4

Effective date: 19890712

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20001130

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20001201

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20001211

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010916

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020501

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20010916

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020531

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST